Background Although guidelines for prophylactic human papillomavirus (HPV) vaccination
recommend two doses for girls ages 9–14 years, several studies have demonstrated similar …

Cervical cancer is the second most common cancer among women in the Philippines.
Human papillomavirus (HPV) vaccination provides protection from the most common cancer …

With the introduction of cervical screening programs, the incidence and mortality of cervical
cancer has been drastically reduced. Techniques such as the traditional Papanicolaou test …

We studied the cost-effectiveness of cervical cancer prevention strategies in the Central and
Eastern Europe and Central Asia (CEECA) region. The cost-effectiveness of human …

Introduction Because of the long interval between infection with high-risk human
papillomavirus (hrHPV) and development of cervical cancer surrogate markers for cancer …

Objective: Three vaccines are available to Taiwanese young girls for cervical cancer (CC)
prevention. Here we evaluate the cost-effectiveness of the two-dose (2D) AS04-adjuvanted …

Background Estonia has high cervical cancer incidence and low screening coverage. We
modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV …

Simulation models are commonly used to address important health policy issues that cannot
be explored through experimental studies. These models are especially useful to determine …

We use an empirically calibrated model to estimate the cost-effectiveness of cervical cancer
prevention in Brazil, a country with a high cervical cancer burden. Assuming 70% coverage …

Cervical cancer is a preventable health problem, yet is the second most common cancer of
women worldwide. More than 80% of cases occur in developing countries, and this is …